Erasca, Inc.

NASDAQ:ERAS

Biotechnology

Healthcare
$13.76 -0.14%

-$0.02 today

Market cap
$4.83B
Beta
0.73
P/E (TTM)
-15.3
EPS (TTM)
-$0.91
52W Low $1.21High $24.28

Volume 8.94M

Average 6.79M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$131.41M

FY 2025 · Annual

Net Income

-$124.55M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue829K2.64M3.73M03.11M
Gross Profit(829K)(2.64M)(3.73M)0(3.11M)
Gross Margin—————
Research & Development73.92M112.46M103.82M115.36M92.85M
Selling, General & Admin22.62M32.99M37.7M41.73M38.55M
Operating Expenses124.05M244.81M137.79M179.59M128.3M
Depreciation & Amortization829K2.64M3.73M3.81M3.11M
EBITDA(121.94M)(240.16M)(121.31M)(153.28M)(121.44M)
EBITDA Margin—————
Operating Income(124.88M)(247.45M)(141.53M)(179.59M)(131.41M)
Operating Margin—————
Interest Income190K4.9M16.71M20.09M16.61M
Interest Expense0201.36M000
Other Income / Expenses2.12M4.65M16.48M17.94M6.86M
Income Before Tax(122.76M)(242.81M)(125.04M)(161.65M)(124.55M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(122.76M)(242.81M)(125.04M)(161.65M)(124.55M)
Net Margin—————
EPS (Basic)(1.03)(1.99)(0.83)(0.69)(0.44)
EPS (Diluted)(1.03)(1.99)(0.83)(0.69)(0.44)
Weighted Avg Shares119.1M122.02M150.18M233.82M283.53M
Weighted Avg Shares (Diluted)119.1M122.02M150.18M233.82M283.53M

ERAS Earnings Waterfall · TTM

NASDAQ:ERAS · Revenue to Net Income

Key Ratios

EPS$-0.99
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-18.3
P/S Ratio0.0

Analysis

$0 of revenue converted into -$307.9M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.99, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
8-KCurrent reportOct 16, 2026
8-KCurrent reportAug 24, 2026
SC 13G/ASC 13G/A filingAug 14, 2026

How much revenue does ERAS generate?

Erasca, Inc. (ERAS) reported $0.00 of revenue in fiscal 2025.

Is ERAS profitable?

Erasca, Inc. (ERAS) reported -$124.55M of net income.